KR20150119118A - 생물학적 샘플의 품질 평가 수단 및 방법 - Google Patents
생물학적 샘플의 품질 평가 수단 및 방법 Download PDFInfo
- Publication number
- KR20150119118A KR20150119118A KR1020157024681A KR20157024681A KR20150119118A KR 20150119118 A KR20150119118 A KR 20150119118A KR 1020157024681 A KR1020157024681 A KR 1020157024681A KR 20157024681 A KR20157024681 A KR 20157024681A KR 20150119118 A KR20150119118 A KR 20150119118A
- Authority
- KR
- South Korea
- Prior art keywords
- biomarkers
- sample
- quality
- biological sample
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 131
- 239000012472 biological sample Substances 0.000 title claims description 55
- 239000000090 biomarker Substances 0.000 claims abstract description 257
- 210000002381 plasma Anatomy 0.000 claims description 125
- 239000000523 sample Substances 0.000 claims description 117
- 238000012545 processing Methods 0.000 claims description 108
- 230000003111 delayed effect Effects 0.000 claims description 92
- 210000004369 blood Anatomy 0.000 claims description 79
- 239000008280 blood Substances 0.000 claims description 79
- 206010018910 Haemolysis Diseases 0.000 claims description 49
- 230000008588 hemolysis Effects 0.000 claims description 49
- 238000004458 analytical method Methods 0.000 claims description 46
- 238000011109 contamination Methods 0.000 claims description 39
- 210000000601 blood cell Anatomy 0.000 claims description 32
- 238000007710 freezing Methods 0.000 claims description 29
- 230000008014 freezing Effects 0.000 claims description 29
- 238000005345 coagulation Methods 0.000 claims description 25
- 230000015271 coagulation Effects 0.000 claims description 21
- 210000002966 serum Anatomy 0.000 claims description 16
- 238000011156 evaluation Methods 0.000 claims description 10
- 238000004422 calculation algorithm Methods 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 238000001514 detection method Methods 0.000 claims description 6
- 238000013441 quality evaluation Methods 0.000 claims description 2
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical group OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 claims 1
- 229930195712 glutamate Natural products 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-L glutamate group Chemical group N[C@@H](CCC(=O)[O-])C(=O)[O-] WHUUTDBJXJRKMK-VKHMYHEASA-L 0.000 claims 1
- 238000002405 diagnostic procedure Methods 0.000 abstract description 3
- 239000002207 metabolite Substances 0.000 description 50
- 150000001875 compounds Chemical class 0.000 description 32
- 238000004949 mass spectrometry Methods 0.000 description 31
- 238000004817 gas chromatography Methods 0.000 description 14
- 238000005259 measurement Methods 0.000 description 14
- 239000000126 substance Substances 0.000 description 14
- 238000013480 data collection Methods 0.000 description 13
- 230000008859 change Effects 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 238000004811 liquid chromatography Methods 0.000 description 12
- 238000013500 data storage Methods 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 10
- 230000002503 metabolic effect Effects 0.000 description 10
- 239000012620 biological material Substances 0.000 description 9
- 210000000265 leukocyte Anatomy 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 238000003556 assay Methods 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 230000005526 G1 to G0 transition Effects 0.000 description 7
- 238000013459 approach Methods 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 7
- 238000004590 computer program Methods 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000001212 derivatisation Methods 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 230000007774 longterm Effects 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 238000004885 tandem mass spectrometry Methods 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 5
- 238000000540 analysis of variance Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000003908 quality control method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- MSPCIZMDDUQPGJ-UHFFFAOYSA-N N-methyl-N-(trimethylsilyl)trifluoroacetamide Chemical compound C[Si](C)(C)N(C)C(=O)C(F)(F)F MSPCIZMDDUQPGJ-UHFFFAOYSA-N 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 150000003943 catecholamines Chemical class 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 150000002066 eicosanoids Chemical class 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000013401 experimental design Methods 0.000 description 4
- 238000003018 immunoassay Methods 0.000 description 4
- 238000001095 inductively coupled plasma mass spectrometry Methods 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 238000012772 sequence design Methods 0.000 description 4
- 238000007619 statistical method Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 230000023555 blood coagulation Effects 0.000 description 3
- 238000013375 chromatographic separation Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000006198 methoxylation reaction Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 238000005191 phase separation Methods 0.000 description 3
- 238000000009 pyrolysis mass spectrometry Methods 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 150000003408 sphingolipids Chemical class 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000002366 time-of-flight method Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 238000004252 FT/ICR mass spectrometry Methods 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 238000000149 argon plasma sintering Methods 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 230000008512 biological response Effects 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000000738 capillary electrophoresis-mass spectrometry Methods 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- XNXVOSBNFZWHBV-UHFFFAOYSA-N hydron;o-methylhydroxylamine;chloride Chemical compound Cl.CON XNXVOSBNFZWHBV-UHFFFAOYSA-N 0.000 description 2
- 238000007884 metabolite profiling Methods 0.000 description 2
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
- 229960001252 methamphetamine Drugs 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000006920 protein precipitation Effects 0.000 description 2
- 238000005173 quadrupole mass spectroscopy Methods 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 125000005480 straight-chain fatty acid group Chemical group 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 238000006227 trimethylsilylation reaction Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 108091023037 Aptamer Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 1
- 208000033962 Fontaine progeroid syndrome Diseases 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 238000012773 Laboratory assay Methods 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 238000001069 Raman spectroscopy Methods 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000009932 biopreservation Methods 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000000835 electrochemical detection Methods 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011152 fibreglass Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000010324 immunological assay Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000004648 ion cyclotron resonance mass spectroscopy Methods 0.000 description 1
- 238000000752 ionisation method Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 238000002705 metabolomic analysis Methods 0.000 description 1
- 238000006140 methanolysis reaction Methods 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000009120 phenotypic response Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000000575 proteomic method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000001303 quality assessment method Methods 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000010845 search algorithm Methods 0.000 description 1
- 238000012764 semi-quantitative analysis Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000005029 sieve analysis Methods 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- -1 small molecule compound Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000010972 statistical evaluation Methods 0.000 description 1
- 238000000528 statistical test Methods 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000563 toxic property Toxicity 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/492—Determining multiple analytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/4905—Determining clotting time of blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/491—Blood by separating the blood components
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Ecology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361764640P | 2013-02-14 | 2013-02-14 | |
| US201361764625P | 2013-02-14 | 2013-02-14 | |
| EP13155310.9 | 2013-02-14 | ||
| US61/764,640 | 2013-02-14 | ||
| EP13155310 | 2013-02-14 | ||
| EP13155318.2 | 2013-02-14 | ||
| US61/764,625 | 2013-02-14 | ||
| EP13155318 | 2013-02-14 | ||
| PCT/IB2014/059002 WO2014125443A1 (en) | 2013-02-14 | 2014-02-14 | Means and methods for assessing the quality of a biological sample |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20150119118A true KR20150119118A (ko) | 2015-10-23 |
Family
ID=51353544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020157024681A Withdrawn KR20150119118A (ko) | 2013-02-14 | 2014-02-14 | 생물학적 샘플의 품질 평가 수단 및 방법 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20160003799A1 (enExample) |
| EP (1) | EP2956127A4 (enExample) |
| JP (1) | JP6388606B2 (enExample) |
| KR (1) | KR20150119118A (enExample) |
| CN (1) | CN105120852A (enExample) |
| AU (1) | AU2014217452B2 (enExample) |
| BR (1) | BR112015019453A2 (enExample) |
| CA (1) | CA2900031A1 (enExample) |
| DE (1) | DE112014000822T5 (enExample) |
| IL (1) | IL240346A0 (enExample) |
| WO (1) | WO2014125443A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210089178A (ko) * | 2018-10-30 | 2021-07-15 | 소마로직, 인크. | 샘플 품질 평가 방법 |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017512996A (ja) * | 2014-03-26 | 2017-05-25 | メタノミクス ヘルス ゲーエムベーハー | 代謝産物パネルに基づく血液サンプルの品質の決定のための手段および方法 |
| CN104713970B (zh) * | 2015-04-01 | 2017-03-15 | 山东省肿瘤医院 | 一种血清代谢组学分析模型的构建方法 |
| US10890592B2 (en) | 2015-11-04 | 2021-01-12 | Metabolon, Inc. | Automated sample quality assessment |
| CN105996126B (zh) * | 2016-07-12 | 2019-06-14 | 福建中烟工业有限责任公司 | 天冬氨酸甘油酯用于降低卷烟烟气中苯酚释放量的用途 |
| JP6779500B2 (ja) * | 2017-03-30 | 2020-11-04 | 株式会社島津製作所 | クロマトグラフ質量分析方法及び装置 |
| EP3628068A4 (en) * | 2017-05-02 | 2020-12-30 | Liquid Biosciences, Inc. | SYSTEMS AND METHODS FOR DETERMINING THE ATTRIBUTES OF BIOLOGICAL SAMPLES |
| JP7348626B2 (ja) * | 2019-07-17 | 2023-09-21 | 国立大学法人山梨大学 | 生体試料の状態評価装置、システム、方法、およびプログラム |
| CN111402961B (zh) * | 2020-02-28 | 2020-11-17 | 上海鹿明生物科技有限公司 | 一种多物种gc-ms内源性代谢物数据库及其建立方法 |
| CN113433239A (zh) * | 2021-06-25 | 2021-09-24 | 郑州大学第一附属医院 | 一种用于贲门癌诊断的标志物及试剂盒 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030232396A1 (en) * | 2002-02-22 | 2003-12-18 | Biolife Solutions, Inc. | Method and use of protein microarray technology and proteomic analysis to determine efficacy of human and xenographic cell, tissue and organ transplant |
| US20090137063A1 (en) * | 2005-11-29 | 2009-05-28 | Karl Skold | Method for determining the quality of a biological sample |
| US8026049B2 (en) * | 2007-03-23 | 2011-09-27 | Wisconsin Alumni Research Foundation | Noninvasive measurement and identification of biomarkers in disease state |
| WO2009014639A2 (en) * | 2007-07-17 | 2009-01-29 | Metabolon, Inc. | Biomarkers for pre-diabetes, cardiovascular diseases, and other metabolic-syndrome related disorders and methods using the same |
| CN101918838A (zh) * | 2007-11-22 | 2010-12-15 | 特拉斯医药有限公司 | 血液试样的品质评估方法 |
| PL2254586T3 (pl) * | 2008-02-22 | 2015-09-30 | Agency For Science Tech And Research Astarstar | Cząstki mezenchymalnych komórek macierzystych |
| US8026102B2 (en) * | 2009-01-21 | 2011-09-27 | Blaze Medical Devices, LLC | Apparatus and method to characterize blood and red blood cells via erythrocyte membrane fragility quantification |
| WO2011041892A1 (en) * | 2009-10-09 | 2011-04-14 | Carolyn Slupsky | Methods for diagnosis, treatment and monitoring of patient health using metabolomics |
| WO2012170669A1 (en) * | 2011-06-07 | 2012-12-13 | Yale University Avenue | Biomarkers for assessment of the molecular quality in biospecimens |
-
2014
- 2014-02-14 AU AU2014217452A patent/AU2014217452B2/en not_active Expired - Fee Related
- 2014-02-14 KR KR1020157024681A patent/KR20150119118A/ko not_active Withdrawn
- 2014-02-14 EP EP14751739.5A patent/EP2956127A4/en not_active Withdrawn
- 2014-02-14 JP JP2015557553A patent/JP6388606B2/ja not_active Expired - Fee Related
- 2014-02-14 BR BR112015019453A patent/BR112015019453A2/pt not_active Application Discontinuation
- 2014-02-14 WO PCT/IB2014/059002 patent/WO2014125443A1/en not_active Ceased
- 2014-02-14 CA CA2900031A patent/CA2900031A1/en not_active Abandoned
- 2014-02-14 DE DE112014000822.2T patent/DE112014000822T5/de not_active Withdrawn
- 2014-02-14 CN CN201480020954.7A patent/CN105120852A/zh active Pending
- 2014-02-14 US US14/767,059 patent/US20160003799A1/en not_active Abandoned
-
2015
- 2015-08-04 IL IL240346A patent/IL240346A0/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210089178A (ko) * | 2018-10-30 | 2021-07-15 | 소마로직, 인크. | 샘플 품질 평가 방법 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2900031A1 (en) | 2014-08-21 |
| WO2014125443A1 (en) | 2014-08-21 |
| CN105120852A (zh) | 2015-12-02 |
| EP2956127A4 (en) | 2016-10-05 |
| EP2956127A1 (en) | 2015-12-23 |
| DE112014000822T5 (de) | 2015-10-29 |
| BR112015019453A2 (pt) | 2017-07-18 |
| IL240346A0 (en) | 2015-09-24 |
| US20160003799A1 (en) | 2016-01-07 |
| AU2014217452B2 (en) | 2018-10-25 |
| JP2016510414A (ja) | 2016-04-07 |
| JP6388606B2 (ja) | 2018-09-12 |
| AU2014217452A1 (en) | 2015-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20150119118A (ko) | 생물학적 샘플의 품질 평가 수단 및 방법 | |
| Picotti et al. | Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions | |
| KR101894111B1 (ko) | 대상체에서 췌장암을 진단하기 위한 수단 및 방법 | |
| KR20160146727A (ko) | 대사물 패널에 기초하여 혈액 샘플의 품질을 결정하기 위한 수단 및 방법 | |
| US8216848B2 (en) | Means and method for diagnosing diabetes | |
| CN101443663A (zh) | 诊断糖尿病的工具和方法 | |
| JP5584680B2 (ja) | ペルオキシソーム増殖の増加を評価する手段及び方法 | |
| JP5068819B2 (ja) | 溶血性貧血を検査するための手段および方法 | |
| JP2015042985A (ja) | 肝酵素誘導を評価する手段及び方法 | |
| JP2017523418A (ja) | 生物学的サンプルの品質を評価するための手段及び方法 | |
| JP2019039915A (ja) | 生物学的サンプルの質を評価するための手段及び方法 | |
| Di Tommaso et al. | Quantitative enrichment of amyloid precursors refines mass spectrometry-based amyloidosis diagnosis | |
| EP2822455A2 (en) | Means and methods for assessing liver disorders | |
| KR20140060523A (ko) | 생식선 독성을 평가하기 위한 수단 및 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20150909 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |